The DOI matches its Crossref record; 17 of the 18 references it cites were found in a registry or an index.
Efficacy of Oral N-Acetylcysteine in the Treatment of Acetaminophen Overdose
Abstract
During the investigational use of oral N-acetylcysteine as an antidote for poisoning with acetaminophen, 11,195 cases of suspected acetaminophen overdose were reported. We describe the outcomes of 2540 patients with acetaminophen ingestions treated with a loading dose of 140 mg of oral N-acetylcysteine per kilogram of body weight, followed four hours later by 70 mg per kilogram given every four hours for an additional 17 doses. Patients were categorized for analysis on the basis of initial plasma acetaminophen concentrations and the interval between ingestion and treatment. Hepatotoxicity developed in 6.1 percent of patients at probable risk when N-acetylcysteine was started within 10 hours of acetaminophen ingestion and in 26.4 percent of such patients when therapy was begun 10 to 24 hours after ingestion. Among patients at high risk who were treated 16 to 24 hours after an acetaminophen overdose, hepatotoxicity developed in 41 percent--a rate lower than that among historical controls. When given within eight hours of acetaminophen ingestion, N-acetylcysteine was protective regardless of the initial plasma acetaminophen concentration. There was no difference in outcome whether N-acetylcysteine was started zero to four or four to eight hours after ingestion, but efficacy decreased with further delay. There were 11 deaths among the 2540 patients (0.43 percent); in the nine fatal cases in which aminotransferase was measured before treatment, values were elevated before N-acetylcysteine was started. No deaths were clearly caused by acetaminophen among patients in whom N-acetylcysteine therapy was begun within 16 hours. We conclude that N-acetylcysteine treatment should be started within eight hours of an acetaminophen overdose, but that treatment is still indicated at least as late as 24 hours after ingestion. On the basis of available data, the 72-hour regimen of oral N-acetylcysteine is as effective as the 20-hour intravenous regimen described previously, and it may be superior when treatment is delayed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Based on large clinical trials, it appears that NAC efficacy is nearly complete as long as it is initiated within 8-10 h of paracetamol overdose (200): there have been no deaths in cases so treated (182).”
From Paracetamol: New Vistas of an Old Drug (2006) · cites this paper as [200]
In the citing paper
“N-Acetylcysteine has been used for many years in clinical praxis to restore hepatic levels of glutathione after acetaminophen overdose (Smilkstein et al. 1988).”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Smilkstein et al. 1988
Citations
Cites
Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning.
Prescott, L. F., Illingworth, R. N., Critchley, J. A., Stewart, M. J., Adam, R. D., & Proudfoot, A. T. (1979) · BMJ · doi:10.1136/bmj.2.6198.1097 · Cited by 667
Acetaminophen Poisoning and Toxicity
Rumack, B. H., & Matthew, H. (1975) · Pediatrics · doi:10.1542/peds.55.6.871 · Cited by 640
Self-citationIntravenous N-acetylcysteine: still the treatment of choice for paracetamol poisoning.
Prescott, L. F., Illingworth, R. N., Critchley, J. A., & Proudfoot, A. T. (1980) · BMJ · doi:10.1136/bmj.280.6206.46-b · Cited by 626
Paracetamol Overdosage Pharmacological Considerations and Clinical Management
Prescott, L. F. (1983) · Drugs · doi:10.2165/00003495-198325030-00002 · Cited by 425
Acetaminophen Overdose: 662 Cases With Evaluation of Oral Acetylcysteine Treatment
Rumack, B. H. (1981) · Archives of Internal Medicine · doi:10.1001/archinte.1981.00340030112020 · Cited by 350
Self-citationCORCORAN, G. B., MITCHELL, J. R., VAISHNAV, Y. N., & HORNING, E. C. (1980) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14551-3 · Cited by 247
CYSTEAMINE, METHIONINE, AND PENICILLAMINE IN THE TREATMENT OF PARACETAMOL POISONING
Prescott, L. F., Sutherland, G. R., Park, J., Smith, I. J., & Proudfoot, A. T. (1976) · The Lancet · doi:10.1016/s0140-6736(76)92842-7 · Cited by 210
PREGNANCY OUTCOME IN INSULIN-DEPENDENT DIABETICS WITH THYROID DISEASE OR PERNICIOUS ANAEMIA
Roman, E., & Beral, V. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90284-8 · Cited by 178
Litovitz, T. L., Schmitz, B. F., Matyunas, N., & Martin, T. G. (1988) · The American Journal of Emergency Medicine · doi:10.1016/0735-6757(88)90252-5 · Cited by 174
Dose-dependent pharmacokinetics of acetaminophen: Evidence of glutathione depletion in humans
Slattery, J. T., Wilson, J. M., Kalhorn, T. F., & Nelson, S. D. (1987) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1987.50 · Cited by 143
Research works printed but not linked: 2
- Davis, 1976, Q J Med, 45, 181
- Bronstein, 1985, Vet Hum Toxicol, 27, 316
Cited by
Targeting oxidative stress in disease: Promise and limitations of antioxidant therapy
Forman, H. J., & Zhang, H. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00233-1 · Cited by 2,900
Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging
Jomova, K., Raptova, R., Alomar, S. Y., Alwasel, S. H., Nepovimova, E., Kuca, K., & Valko, M. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03562-9 · Cited by 2,638
Lee, W. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021844 · Cited by 1,594
Biologic and pharmacologic regulation of mammalian glutathione synthesis
Griffith, O. W. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00176-8 · Cited by 1,190
Glutathione in Cancer Biology and Therapy
Estrela, J. M., Ortega, A., & Obrador, E. (2006) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360500523878 · Cited by 1,041
Metadata
- Authors
- Smilkstein, M. J., Knapp, G. L., Kulig, K. W., & Rumack, B. H.
- Affiliations
- Denver Health Medical Center (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1988-12-15
- Volume
- 319
- Issue
- 24
- Pages
- 1557-1562
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2333107025
- Cited by
- 1,102
- References
- 18
- Citations by year
- 2026: 18 · 2025: 27 · 2024: 42 · 2023: 33 · 2022: 38 · 2021: 49 · 2020: 36 · 2019: 31 · 2018: 34 · 2017: 39 · 2016: 44 · 2015: 43 · 2014: 33 · 2013: 35 · 2012: 28
- FWCI
- 24.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Paraquat toxicity studies and treatments
- Keywords
- N-acetylcysteine, acetaminophen overdose, antidotes, hepatotoxicity, treatment timing, transaminases, mortality, oral administration, intravenous administration, drug poisoning
- MeSH terms
- Acetaminophen, Acetylcysteine, Administration, Oral, Transaminases, Humans, Liver, Mortality, Time Factors, Multicenter Studies as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy of Oral N-Acetylcysteine in the Treatment of Acetaminophen Overdose. https://app.cochat.ai/papers/10.1056/nejm198812153192401
- The paper
- Smilkstein, M. J., Knapp, G. L., Kulig, K. W., & Rumack, B. H. (1988). Efficacy of Oral N-Acetylcysteine in the Treatment of Acetaminophen Overdose. New England Journal of Medicine. https://doi.org/10.1056/nejm198812153192401
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.